skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:022645/0833   Pages: 7
Recorded: 05/07/2009
Attorney Dkt #:03153.0001.000000
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 12
1
Patent #:
Issue Dt:
02/01/2005
Application #:
09756293
Filing Dt:
01/09/2001
Publication #:
Pub Dt:
12/06/2001
Title:
HYBRID CELLS
2
Patent #:
Issue Dt:
04/10/2007
Application #:
09815306
Filing Dt:
03/23/2001
Publication #:
Pub Dt:
06/06/2002
Title:
BI-FUNCTIONAL CANCER TREATMENT AGENTS
3
Patent #:
Issue Dt:
08/22/2006
Application #:
09851422
Filing Dt:
05/09/2001
Publication #:
Pub Dt:
06/20/2002
Title:
THERAPEUTIC PORE-FORMING PEPTIDES
4
Patent #:
Issue Dt:
11/25/2008
Application #:
09938623
Filing Dt:
08/27/2001
Publication #:
Pub Dt:
04/18/2002
Title:
LYTIC PEPTIDE PRODRUGS
5
Patent #:
Issue Dt:
10/03/2006
Application #:
10140293
Filing Dt:
05/08/2002
Publication #:
Pub Dt:
01/30/2003
Title:
USE OF ANTI-PROLACTIN AGENTS TO TREAT PROLIFERATIVE CONDITIONS
6
Patent #:
Issue Dt:
12/15/2009
Application #:
10419976
Filing Dt:
04/22/2003
Publication #:
Pub Dt:
02/19/2004
Title:
MULTIMERIC LIGANDS WITH ENHANCED STABILITY
7
Patent #:
Issue Dt:
03/04/2008
Application #:
10449609
Filing Dt:
06/02/2003
Publication #:
Pub Dt:
07/01/2004
Title:
HUMAN PROLACTIN ANTAGONIST-ANGIOGENSIS INHIBITOR FUSION PROTEINS
8
Patent #:
Issue Dt:
06/17/2014
Application #:
11073927
Filing Dt:
03/08/2005
Publication #:
Pub Dt:
12/08/2005
Title:
Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
9
Patent #:
Issue Dt:
09/16/2008
Application #:
11123182
Filing Dt:
05/06/2005
Publication #:
Pub Dt:
12/01/2005
Title:
THERAPEUTIC PORE-FORMING PEPTIDES
10
Patent #:
Issue Dt:
06/23/2009
Application #:
11131443
Filing Dt:
05/18/2005
Publication #:
Pub Dt:
11/23/2006
Title:
ACETYLATED THERAPEUTIC PROCYTOTOXINS
11
Patent #:
NONE
Issue Dt:
Application #:
11702661
Filing Dt:
02/06/2007
Publication #:
Pub Dt:
09/13/2007
Title:
Hybrid cells
12
Patent #:
NONE
Issue Dt:
Application #:
11802566
Filing Dt:
05/23/2007
Publication #:
Pub Dt:
04/02/2009
Title:
Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
Assignor
1
Exec Dt:
01/24/2007
Assignee
1
14405 WALTERS ROAD
SUITE 1008
HOUSTON, TEXAS 77014
Correspondence name and address
DAVID W. CLOUGH, PH.D.
HOWREY LLP
321 N. CLARK STREET, SUITE 3400
CHICAGO, IL 60654

Search Results as of: 06/24/2024 09:57 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT